Gynecol Oncol. 2015 Aug 26. pii: S0090-8258(15)30107-4. doi: 10.1016/j.ygyno.2015.08.015. [Epub ahead of print]
Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC).
Seifert H1, Georgiou A1, Alexander H1, McLachlan J1, Bodla S2, Kaye S1, Barton D1, Nobbenhuis M1, Gore M1, Banerjee S3.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου